1. Eli Lilly will participate in the Bernstein Healthcare Forum on September 25. 2. CFO Lucas Montarce will represent LLY in a scheduled fireside chat. 3. Live webcast available on Lilly's investor website for stakeholders. 4. Presentation replay accessible for 90 days after the event. 5. Lilly focuses on pioneering solutions to significant health challenges.
While participation in a healthcare forum can boost visibility, it typically does not lead to immediate stock price changes, indicating that LLY's fundamentals remain unchanged at this point. Past forum participations have often resulted in marginal or no price fluctuations unless specific announcements or data are released.
This article indicates ongoing engagement by Lilly but doesn't present groundbreaking information that would shift investor sentiment drastically. The forum can create short-term interest but lacks immediate financial implications.
The impact is closely tied to the upcoming event, but generally, discussions at forums lead to temporary interest rather than significant long-term shifts in stock price. Investors may react based on the insights shared during the forum, particularly if they pertain to pivotal product developments.
INDIANAPOLIS, Sept. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein's 2nd Annual Healthcare Forum on September 25, 2025. Lucas Montarce, executive vice president and chief financial officer, will take part in a fireside chat at 8 a.m., Eastern time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-bernsteins-2nd-annual-healthcare-forum-302553180.html
SOURCE Eli Lilly and Company